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Background: The World Health Organization (WHO) recommends that intermittent preventive treatment with
sulfadoxine-pyrimethamine (IPTp-SP) and insecticide treated bed nets (ITNs) must be provided during antenatal
care (ANC) visits for malaria prevention during pregnancy. The aim of this study was to determine the level of ANC
attendance and its relationship with IPTp-SP and bed net coverage in Gabonese pregnant women.
Methods: This was a cross-sectional survey performed in 2011 in sentinel sites for malaria: two ANC units (Melen
and Owendo) and one delivery unit (CHL). A validated structured questionnaire was used to collect the following
data: age, parity, history of the current pregnancy including gestational age at the interview, number of ANC visits
already performed, date of first visit, use of malaria preventive measure and details on IPTp-SP administration.
Results: During the study, 1030 women were interviewed, 735 at their ANC visit and 295 at the delivery. Their
median age was 24[20–29] years and 21.0% were primigravidae. More than 70.0% attended their first ANC visit
during the second trimester. Among the 442 women who were at the end of their pregnancy, 71.5% had a correct
attendance, at least four ANC visits, most frequently women with no education and older women; IPTp-SP was
offered to 84.1% of them and 57.4% received at least two doses. The number of SP doses was correlated to the
number of ANC visits. Bed net coverage was 59.0%, not associated with ANC attendance. Among the women with
correct ANC attendance, only 49.5% had a complete IPTp-SP course associated with bed net use during pregnancy.
In the site where SP administration was supervised, 80% had four ANC visits and 97.4% received a full 2-dose
course of IPTp-SP.
Conclusions: Despite a high level of correct ANC attendance in Gabon, the goal of 80% of women with 2-dose
IPTp-SP during pregnancy is not achieved. Evaluations, training of health workers, as well as surveys from other
areas of the country are needed to further measure the implementation and the impact of these strategies.Background
In 2007, about 32 million women were pregnant in mal-
aria endemic areas in Sub-Saharan Africa [1]. The World
Health Organization (WHO) guidelines for malaria pre-
vention during pregnancy include use of intermittent
preventive treatment with sulfadoxine-pyrimethamine
(IPTp-SP), sleeping under an insecticide treated bed net
(ITN) and prompt management of malaria cases and an-
aemia [2]. These strategies have been adopted by 35 of* Correspondence: mariellebouyou@gmail.com
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distribution, and reproduction in any mediumthe 45 African endemic countries including Gabon, and
should be delivered through collaboration between re-
productive health systems and malaria control programs,
during the four target antenatal care (ANC) visits
throughout the pregnancy as recommended by WHO
[2-5]. Although a high proportion of pregnant women
had an ANC visit at least once during pregnancy, cover-
age level of IPTp-SP and ITNs remains low in Sub-
Saharan Africa [6-8]. In 2010, it was estimated that 55%
of pregnant women received a full IPTp-SP dose (at
least two curative doses) during ANC visits [3]. Few
studies have analyzed the relationship between the
number of ANC visit, IPTp-SP and bed net coverage,
the reported data are controversial [8,9]. In Gabon,Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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have attended ANC at least twice during their preg-
nancy, correct IPTP-SP and bed net coverage were
estimated at around 56% and 50% in 2006, respectively
[10]. Awareness campaigns in recent years for both
health workers and pregnant women were organized
by the Gabonese Malaria National Control Program
(MNCP) supported by the Global Fund. An evaluation
of the implemented programs is needed, including the
key indicators of intervention coverage, ANC visit
planning and attendance, health workers adherence to
the recommendations and local socio-demographic and
economic factors [11-13]. We present in this study the
quality of care for pregnant women through ANC at-
tendance and its relationship with access to adequate
malaria preventive measures in Libreville.
Methods
Malaria transmission is perennial in Gabon with slight
seasonal fluctuations. The annual entomological inocula-
tion rate is estimated at 33.9 infected bites per person
per year, Anopheles gambiae s.s is the predominant vec-
tor [14]. Plasmodium (P.)falciparum infection prevalence
is respectively of 24%, 31% and 11% at Libreville, Melen
and Owendo.
Study sites
MNCP has five sentinel sites (represented by one public
hospital in five provinces) for malaria survey and man-
agement across the country. This baseline survey took
place in the Centre Hospitalier de Libreville (CHL) and
the Regional Hospital of Melen (RHM), two sentinel
sites located in and around the capital city of Libreville,
where more than 45% of the Gabonese population
resides; and at the public reproductive health centre
at Owendo (HCO), a suburban area located at 25
kilometers from the capital city. According to the na-
tional reproductive health program organization, women
have access to ANC visits, ITNs and IPTp in public
health centers of the city.
Study type and population
This study is a cross-sectional and observational survey
conducted from March 2011 to September 2011. Ante-
natal care and delivery units were surveyed during a
10 week- period following a two to three week planning
and discussion with health centre teams. To assess the
burden of malaria during pregnancy, a structured ques-
tionnaire adapted from the framework proposed by the
CDC, was prepared by the team of the Department
of Parasitology at the Faculty of Medicine, University
des Sciences de la Santé in Libreville. All eligible women
attending ANC and delivery units were invited to
participate and oral consent was required beforeproceeding. Women were eligible for the survey if they
met the following criteria: had experienced quickening
(i.e., the recognition of fetal movement) during ANC or
were nearing the end of a normal pregnancy; had a nor-
mal (non complicated) delivery; and were older than
14 years.
Administration of the survey
Each women attending the ANC or the delivery unit was
interviewed by a field worker and the midwives for 15 -
minutes. Socio-demographic data including age, resi-
dence, language used at home, matrimonial status,
education level, and profession of the head of the house-
hold were recorded. Antenatal data were obtained from
either the antenatal card or the register of the centre
with assistance of a midwife and included: parity, gesta-
tional age at the interview, number of ANC visits already
performed, date of the first visit. Gestational age was
determined, after the physical examination by the mid-
wife who used a gestational calendar or uterine growth
when the date of last menses was not known. Use of
malaria prevention was recorded from both ANC card
and the health centre maternal care register. If preven-
tion was performed, the type of medicine taken was
recorded as well as the first time of dosing, the number
and dates of drug administration, and the number of
tablets taken. Women were asked if they sleep under a
bed net, if they used it the night before the interview, if
the net was treated with insecticide or if it was a long
lasting insecticide treated net.
Sample size estimation
Sample size was calculated by considering the previous
data estimating that i) 80% of pregnant women have
at least 2 ANC visits, complete ANC attendance is
estimated to be between 50% and 70%, ii) IPTp-SP
coverage was at 50% in 2006 and will be between 60 to
70% five years later, and iii) each year less than 2000
women are received in each reproductive health service
[8,9]. A sample size calculation was done using STATA
software and Epi-Info 6 with a “design effect” of 2 (since
the present survey is not a random community sample
study), a risk of 5% and a 90% power. Therefore a total
number of 360 interviewed pregnant women (120 per
unit) was estimated.
Data management and analysis
A full course IPTp-SP was defined as at least a complete
2-dose course of SP administered during the pregnancy.
As the investigators worked closely with the midwives
during ANC, sites were classified according to the way the
SP was given to the women: supervised SP administration
when complete dose was given as directly observed by the
nurse and unsupervised SP administration when complete







- Median [IQR] 24 [20–29] 26 [21–30]
- <20 years, n(%) 224 (21.8) 80 (18.1)
- 20–25 years, n (%) 292 (28.4) 123 (27.8)
- >25 years, n (%) 512 (49.8) 239 (54.1)
Primigravidae, n (%) 216 (21.0) 85 (19.2)
Bednet use, n (%) 608 (59.0) 261 (59.0)
IPTp-SP, n (%) 830 (80.6) 372 (84.1)
IPTp-SP 1rst dose, n (%)
1rst trimester 49 (5.9)
2nd trimester 658 (79.3)
3rd trimester 123 (14.8)
First ANC visit, n (%)
1rst trimester 225 (21.8)
2nd trimester 766 (74.4)
3rd trimester 39 (3.8)
* : age unknown for two women.
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Site supervisors checked all questionnaires for complete-
ness every day at the end of all interviews. The log of
enrollees and refusals for both the antenatal care clinic
and delivery were kept up to date. Two data entry clerks
double entered the data using Epi info version 2000 and
analyzed with Stata 9.2 (Stata Corporation, College Station,
TX USA). Continuous data are presented as medians [25th
and 75th percentiles]. Differences between groups were
assessed using chi-squared or Fisher’s exact tests for
proportions, Student’s t-test, analysis of variance (ANOVA)
or Kruskal-Wallis test as appropriate. Spearman’s test was
used to assess the correlation between continuous variables.
The association between some variables was assessed in
univariate analysis using odds ratio and the 95% confidence
interval (OR (95%CI)). A p-value of less than 0.05 was
considered significant.
Ethical consideration
The study was approved by the Gabonese Ministry of
Health (GMH). Prompt malaria diagnosis and accurate
treatment, drug resistance monitoring and interventions
coverage in sentinel sites are the main strategies for
malaria control of the GMH represented by the MNCP.
The Department of Parasitology-Mycology (DPM) is the
reference laboratory for malaria survey including diagno-
sis, anti-malarial drug resistance evaluation, treatment
efficacy and impact of control strategies. The DPM (in-
cluding the MCORU) is committed by the GMH to
carry out these evaluations in collaboration with MNCP
throughout the country, in order to provide reliable data
for policy adjustment. All data obtained are part of rou-
tine activities in sentinel sites and at HCO that are
under the administrative supervision of the MH.
Women were informed about the study protocol, and
their oral consent was required prior to the interview
and for data publication.
Results
Characteristics of the study population
Overall, 1030 women were interviewed, 735 were seen in
ANC units, either at Owendo (n = 219) or Melen (n = 516)
and 295 delivered at the CHL. Their median age was 24
[20-29] years, the mean gravidity of 3[2-5], 79.0% and
21.8% were multigravidae and teenagers (younger than 20 -
years old) respectively (Table 1). Pregnant women aged
less than 17 years old represented 23.8% (n = 19/80) of the
teenagers. The median gestational age was 33[25–38]
weeks; the proportion of women in the 2nd trimester
was 30.3%. Malaria preventive measures were not used by
96 (9.3%) women and among the 608 (59.0%) who had a
bed net at home, 547 (90.0%) used it the night before the
interview. A total of 34.0% of the nets used were
insecticide-treated.Antenatal care attendance
The majority of women (n = 766) attended their first
visit during the 2nd trimester (Table 1).
Data from women who completed their last ANC visit
and who delivered at the CHL (n = 442) were used to
examine the association between ANC attendance, use
of bed nets and IPTp-SP. This group differed from the
overall population: they were older (median age, 26 ver-
sus 24 years) and had a lower proportion of young
women (p < 0.01). Only 3.4% (n = 15) had one ANC visit
and 71.5% had at least four ANC visits during the
present pregnancy. Median age was the highest in the
group of women with complete ANC attendance
(considered to be at least four ANC visits during preg-
nancy); and 15.2% of them had higher educational status,
this proportion was three fold lower in the group of
those with an incomplete attendance (Table 2). A trend
towards a better ANC attendance was also observed in
primigravidae women (Table 2).
ANC attendance and IPTp-SP and bed net use
Bed net coverage did not differ according to the total
number of ANC visits (Table 2). IPTp-SP was offered to
more than 80% of the population, and the first dose was
taken usually between 16 to 28 weeks of pregnancy,
though 14.8% of women received it during the 3rd tri-
mester (Table 1). Among women interviewed at term or
delivery, 26.7% (118/442) had one dose of IPTp-SP (in-
complete IPTp-SP), this concerned 39.2% of those with
less than three ANC visits, and 21.8% of women from
Table 2 Relationship between ANC visits, individual
factors and use of preventive measures
≤ 3 ANC visits
(n = 126)
≥ 4 ANC visits
(n = 316)
Age in years, median [IQR] 24 [20–29] 26 [21–30]
- <20 years, n(%) 29 (23.0) 51 (16.1)
- 20–25 years, n (%) 43 (34.1) 80 (25.3)
- >25 years, n (%) 54 (42.9) 185 (58.6)
Primigravidae, n (%) 17 (13.5) 68 (21.5)
Multigravidae, n (%) 109 (86.5) 248 (78.5)
Education status, n (%)
- None 1 (0.8) 17 (5.3)
- Primary school 21 (16.7) 41 (13.0)
- Secondary school 97 (77.0) 210 (66.5)
- High school 7 (5.5) 48 (15.2)
Marital status, n (%)
- Single 5 (4.0) 38 (12.0)
- Married 121 (96.0) 278 (88.0)
IPTp-SP, n (%) 104 (82.5) 268 (84.8)
1 dose IPTp-SP, n (%) 49 (47.1) 69 (25.7)
≥2 doses IPTp-SP, n (%) 55 (52.9) 199 (74.3)
Bed net use, n (%) 82 (65.1) 179 (56.6)
Bouyou-Akotet et al. BMC Pregnancy and Childbirth 2013, 13:52 Page 4 of 6
http://www.biomedcentral.com/1471-2393/13/52the group with complete attendance. The proportion of
women receiving the full 2 or 3 doses of IPTp-SP was
57.5% (254/442), it increased with the number of ANC
visits attended (Table 3). The number of SP doses was
correlated with the number of ANC visits (Rho = 0.32, p
< 0.01). A complete IPTp-SP course was more frequently
administered to women with correct ANC attendance
(63.0%) compared to the other group (43.7%).
Among the 48 women with complete attendance who
did not use any IPTp-SP, 27 (56.2%) said that they
received SP tablets from the midwife and they did notTable 3 IPTp-SP and bed net use according to number of
antenatal care visits
Number of antenatal visits
1 2 3 4 5 ≥6
n = 15 n = 27 n = 84 n = 146 n = 95 n = 75
SP doses without bed net use, n (%)
0 4 (26.7) 4 (14.8) 2 (2.4) 11 (7.5) 9 (9.5) 7 (9.3)
1 2 (13.3) 2 (7.4) 9 (10.7) 13 (8.9) 9 (9.5) 10 (13.4)
2 0 (0.0) 3 (11.1) 18 (21.4) 31 (21.2) 23 (24.2) 20 (26.7)
3 0 (0.0) 0 (0.0) 0 (0.0) 3 (2.1) 0 (0.0) 1 (1.3)
0 or 1 SP dose + bed net use
n, (%) 9 (60.0) 8 (29.7) 31 (36.9) 34 (23.3) 17 (17.8) 7 (9.3)
≥2 SP doses + bed net use (correct prevention)
n, (%) 0 (0.0) 10 (37.0) 24 (28.6) 54 (37.0) 37 (39.0) 30 (40.0)want to take it, while the remaining women (n = 21) did
not give any reason. Although correct ANC attendance
was achieved in 71.5% of interviewed women, the pro-
portion of those with correct malaria prevention
(defined as at least two doses of SP associated with bed
net use) was less than 50.0% (n = 155/316; 49.5%).
All the teenagers below 17 years old had at least three
ANC and only two did not take IPTp-SP during their
pregnancy; 63.2% (n = 12/19) of them received 2 doses,
the same proportion slept under a bed net. Less than one
third (n = 6/19; 31.6%) had a correct malaria prevention.
Site to site health worker practice comparison
The ANC units of Melen and Owendo were compared
according to the type of IPTp-SP administration by the
midwives using the data from a subset of 157 women
interviewed during their last antenatal care visit. At
Owendo, SP was given orally to the women (n = 38) during
ANC visit (supervised administration), whereas women
attending in Melen (n = 119) took the drug at home (un-
supervised administration). The majority of women from
Owendo (n = 37; 97.4%) received a full course of IPTp-SP
(≥ two doses), this was the case for only 64 (53.8%) of those
interviewed at Melen. Similarly, 68% (n = 26/38) of women
had a correct malaria prevention (IPTp ≥ two doses plus
bed net) at Owendo, this concerned only 37% (n = 44/119)
of pregnant women from Melen.
Discussion
The WHO recommends at least four ANC visits, with
three of them occurring after quickening, for pregnant
women in order to receive and appropriate health care
and timely intervention for malaria prevention strategies
[2,5]. Our study confirms the high coverage of ANC at-
tendance in Gabon, which ranged from one to eight visits.
The WHO goal of four ANC visits was met by more than
70% of the interviewed women. This is considerable when
compared to West and East Africa [9,15-17]. Improve-
ment of strategies for pregnant woman care can explain
this high attendance. Several community health centers
and public hospitals, where health care services have been
made affordable for the middle and low-income popula-
tion, were built in the country these last five years. IPTp-
SP is freely provided to the mothers and is always available
in all the public health centers, even in the remote areas;
and the cost of an ANC consultation is officially free of
charge. Furthermore, each delivering woman must show
an ANC card when arriving at the delivery unit they are
distributed only during ANC. The timing of ANC was also
found to be correct, with the majority of women having
their first visit during the second trimester. Education
sessions and oral communication from older women and
mothers who encourage young pregnant women to go to
ANC at three months of gestation may contribute to this.
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visit, reports the schedule in the ANC card and highlights
each time the next appointment.
Regular attendance leads to the prevention, identifica-
tion and treatment of maternal illnesses and obstetric
complications. The Gabonese Ministry of Health
recommends at least one dose of SP in the second tri-
mester and one dose in the third trimester for malaria
prevention, administered through ANC visits. Data from
sentinel sites show acceptable adherence of midwives to
these guidelines. IPTp-SP coverage is over 80%, it is
considered high when compared to some countries
where strategies have been adopted for more than 10 -
years [16-18]. Nevertheless, the goal of 80% coverage of
two full course doses of SP has not yet been reached
(57.4%), although the observed coverage is in range with
reports from other settings [9,16-19]. In 2007, 56% of
delivering women in the CHL received a correct chemo-
prophylaxis; it is noteworthy that this frequency has not
increased over the last four years. The fact that almost
40% of delivering women with more than three ANC
visits had no or partial SP uptake is a proof that several
ANC visits are not sufficient to ensure complete IPTp
coverage; barriers to complete IPTp coverage need to be
explored. Indeed, comparison between on-site practices
showed that when SP administration is supervised,
coverage increases and ANC attendance is substantial.
Adolescent mothers from Sub-Saharan Africa are
known to initiate ANC attendance late with a higher risk
of low birth weight [20,21]. The present data suggest a
better attendance for this population. The number of
teenagers below the age of 17 years is too few to draw a
conclusion and this study was not designed for this ana-
lysis. However, it would be interesting to investigate the
behaviors of this subgroup several years after the previ-
ous study performed in Libreville and Lambaréné, and
also after the implementation of new maternal and child
health policy in the country [21].
This was not a survey evaluating knowledge and
practices. An assessment of individual factors that may in-
fluence uptake of malaria prevention strategies revealed
that high education level and higher gravidity did not pre-
dict complete attendance and good prevention. As previ-
ously stated, incomplete IPTp-SP may not be a problem
deriving from pregnant women but a health center
strengthening issue [9,21].
Bed net coverage is still low, below 60%. Although its
utilization has been found to be associated with a
reduced risk of malaria, it is difficult to assess its real
coverage and impact. They are not always available in
health centers where they are supposed to be distributed.
ITNs distribution campaigns are organized from time to
time in our country by the MNCP, there is no daily dis-
tribution to all pregnant women presenting at their firstprenatal visit in all the health centers. Only one third
(34%) of all the bed net used by the women are ITNs
confirming the coverage model proposed by WHO [3].
Our study has some limitations. It was conducted in the
capital city and surrounding areas, and may overestimate
actual ANC visits and use of SP as attitudes and practices
may differ from those in rural areas in terms of access to
health care, health worker motivation and training, and
availability of health service. Knowledge of malaria
symptoms and prevention among pregnant women and
health workers, as well as a correct evaluation of attitude
and practice of midwives including lack of adherence to
guidelines for offering IPTp-SP to all eligible women, were
not performed in this survey. All these factors may influ-
ence the use of malaria preventive measures [18,22-25].
Conclusion
Six years after the implementation of malaria control
strategies according to the WHO in Gabon, this baseline
survey performed at sentinel sites highlights that despite
high complete ANC attendance, the use of full courses
of IPTp-SP is still sub-optimal and insufficient. Evalu-
ation and training of health workers, as well as surveys
from other areas of the country are needed to further
measure the impact of these strategies.
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